IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
31 hedge funds and large institutions have $2.99M invested in ImmunoCellular Therapeutics, Ltd. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$229K | |
| 2 | +$79.5K | |
| 3 | +$76K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$26.8K |
Top Sellers
| 1 | -$148K | |
| 2 | -$86.2K | |
| 3 | -$62K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$57K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$45K |